Summary: We have evaluated a new diagnostic kit for the enzymatic determination of creatinine in serum, plasma and urine. The method was found to be linear up to 1000 μπιοΐ/ΐ. Within-run precision had a coefficient of variation of 3.1-5.6 % for normal to slightly elevated values and of 2.3-3.3 % for values of about 320 μπιοΐ/ΐ. Day-to-day precision was found to be 7.8 and 5.7 % for values of 94 and 141 μπιοΐ/ΐ, respectively. Mean analytic recovery was 98 %. Bilirubin and hemoglobin did not interfere in concentrations up to 490 and 240 μιηοΐ/ΐ, respectively. The influence of lipids was studied. Correlation studies were done with two other methods, the Technicon SMA 12/60 method and the Dutch standard manual method.
Here, we report our experience with the Boehringer test kit, with regard to linearity, precision, recovery and interference of bilirubin, hemoglobin and lipids. Furthermore, we checked if commercial sera could be used for quality control purposes. Finally, we compared this method with two other methods, the Technicon SMA 12/60 method, which is in routine use in our laboratory, and the manual Dutch standard method.
the manufacturers' instructions for measurement at 340 nm. We halved all volumes mentioned in the instruction sheet. All samples were analyzed in duplicate.
Materials and Methods

Equipment
All absorbance measurements were performed at 340 nm on a Beckman model 25 spectrophotometer. The instrument is checked regularly with respect to wavelength (holmium) and absorbance (cobalt sulphate) according to Rand (6) . For pipetting we used Eppendorf pipets with Eppendorf disposable tips.
Creatinine
Creatinine was purchased from E. Merck AG (cat. no. 5208).
Bilirubin
Bilirubin p.a. was obtained from E. Merck AG (cat.no. 24519). A stock solution of bilirubin (5000 μηιοΐ/ΐ) was prepared according to Dybkaer & Hertz (7) and small volumes of this solution were added to serum samples. Final bilirubin concentrations in the serum samples were checked on our DuPont Automatic Clinical Analyzer (aca).
Hemoglobin
A red cell hemolysate was prepared according to van Assendelft (8) . Small volumes of this hemolysate were added to serum samples. Final hemoglobin concentrations were checked with the method of Crosby & Furth (9) .
Technicon SMA 12/60 method Creatinine determinations were performed according to the normal SMA 12/60 procedure. The creatinine tubing system of our SMA 12/60 has been slightly modified by IJpma et al. (10) .
Manual methods
For serum and urine determinations we used the methods of the Dutch Standardization Committee on Clinical Chemistry. The serum procedure is highly comparable to the method of Knoll & Wisser (11) . All samples were analyzed in duplicate.
Enzymatic method
The enzymatic method (Boehringer Mannheim Test Combination Creatinine Enzymatic, cat. no. 166413) was applied according to
Results
Six different human serum pools were used for precision studies. Samples used for day-to-day precision studies were kept at -20 °C until needed. The results for the enzymatic method are given in table 1.
For comparison, samples 2 and 4 from table 1 gave within-run coefficients of variation of 1.1 and 0.9 %, respectively on our SMA 12/60 (n = 20). the manual method had within-run coefficients of variation of 4.0 and 1.1 % for values of 86 and 538 μπιοΐ/ΐ respectively (n=10).
Linearity
Linearity was checked with primary standards. The enzymatic method was linear up to 1000 /nnol/1, as is shown in figure 1 .
Since linearity is limited by the available amount of NAPH in the reaction mixture and since serum itself contains substances that can convert NADH to NAD + , the linearity limit in serum may not be that high. In the instruction sheet an upper limit of 712 μιηοΐ/ΐ is mentioned. In all further experiments we performed, every sample with a creatinine concentration exceeding that limit was diluted with saline.
Recovery
To six different human sera with creatinine concentrations ranging from 66 to 224 μπιόΙ/1, small volumes of an aqueous creatinine solution (10 mmol/1) were added. Table 2 shows the results of these recovery experiments. Mean analytic recovery was found to be 98%. 
Interferences
Bilirubin and hemoglobin were added to different serum pools (see materials and methods). The effects of increasing concentrations of bilirubin and hemoglobin are summarized in table 3.
The influence of lipemia was checked with 22 lipemic sera. The degree of Upemia, judged qualitatively, ranged from slightly to severely lipemic. In general/lipemic samples can cause measuring problems because of the turbidity of the serum-reagent mixture. 19 of the 22 lipemic sera, with triglyceride concentrations in the range of 2.7 to 7.5 mmol/1 and cholesterol concentrations up to 11 mmol/1, could be measured without problems. The other three lipemic sera had triglyceride concentrations of 9.0, 32.6 and 36.0 mmol/1 and could not be measured without predilution of the samples. Both last mentioned sera had to be diluted 5 times. The 19 aforementioned sera are represented in figure 2.
To check the interference of anticoagulants, we added different anticoagulants to a serum pool in concentrations commonly used. The results are represented in table 4.
A commonly used preservative, sodium azide, in a concentration of 1 g/1, was shown to have no effect on the measured creatinine concentration.
Split-sample comparisons
We compared the enzymatic method with two other methods, the SMA 12/60 method and the Dutch standard manual method (see materials and methods). Serum samples were analyzed in duplicate by the three aforementioned methods, urine samples were analyzed in duplicate by the three aforementioned methods, urine samples were analyzed with the enzymatic and manual method only. 
Control sera
The instruction sheet states that occasionally a serum sample can have a very high NADH consuming activity due to substances in the serum itself (e.g. pyruvate), so that the amount of NADH in the reaction mixture is not adequate. In our experiment series, we noticed this effect twice, once with a human serum arid once with a commercial serum (a Technicon SMA 12/60 calibration serum). In this last serum, the measured creatinine concentration was virtually zero (calibration value: 430 μπιοΐ/ΐ). When we monitored the absorbance of the serum blank during the incubation time, we found an absorbance decrease, which was equivalent to the total amount of NADH in the reaction mixture, so all available NADH was consumed by substances in the serum itself. To check if pyruvate was responsible for this effect, we determined the pyruvate concentration in the Technicon serum with a Boehringer test kit (Test Combination Pyruvate, cat. no. 124982). The concentration we found was 92 /imol/1, which is higher than the normal range given in the instruction sheet (41-67 μιηοΐ/ΐ). However, this amount cannot possibly cause the absorbance decrease we observed. In order to investigate whether this effect also applied to other commercial control and calibration sera, we checked 16 different commercial sera from several manufacturers, with the enzymatic and the manual method. We did not notice the effect in any of these sera. Table 5 specifies the commercial sera we used. The concentration values we measured with both methods are represented in figure 3 .
Discussion
In this report, we have evaluated a new diagnostic kit for the enzymatic determination of creatinine. The method was found to be linear up to 1000 μπιοΐ/ΐ, tested with aqueous standards. As we already mentioned, the upper limit may not be that high in serum, due to the NADH consumption by substances in the serum itself. Mean analytic recovery was 98 %, which agrees well with the results ofSzasz &Borner (5) and Wahlefeld et al. (4) . The results of our precision studies also agree with those of the aforementioned authors. Both the enzymatic method and the manual method had comparable precisions, whereas the SMA 12/60 showed a slightly better precision. The coefficients of variation we found compare favourably with the value which is presented as a goal for analytical performance by the College of American Pathologists in the work of Gilbert (12), i.e. a coefficient of variation of 6.7 % at 132 μτηοΐ/ΐ.
Bilirubin did not interfere with the reaction, even in very high concentrations (up to 490 μιηοΐ/ΐ). Hemoglobin in concentrations above 240 μιηοΐ/ΐ lowered the measured creatinine values. Possibly other components from the red cells are responsible for this effect too. Serum hemoglobin concentrations above 240 μτηοΐ/ΐ are rare, but may sometimes be found in pediatric samples (13 (14) , the method is not disturbed by a number of common drugs.
Lipemic samples, which are represented in figure 2, do not appear to behave differently from non-lipemic sera. If possible, we feel that dilution should be avoided because ol the possibility that the diluted serum sample will have a very low creatinine concentration, which cannot be measured with great precision.
Commonly available control sera can be used for quality control purposes, although we feel that care should be taken because of our experience with the Technicon serum.
Correlation of the enzymatic method with both of the other methods was good. Our enzymatic values were consistently lower than the values we obtained with either the manual or the SMA 12/60 method, but we did not find a 20-25 % difference, as is reported by Szasz & Börner (5). We have not yet studied the possible causes of these differences.
Another important aspect of the test kit is its price. The reagent price for one single enzymatic test is very high, when compared to the reagent price for one single manual or SMA 12/60 test, which is virtually negligible. However, with the manual method not more than 30-40 tests could be performed within 3 hours, whereas with the enzymatic test 60 tests could be performed in 1.8 hours. When a price for one test (i.e. reagent cost + personnel cost) is calculated on the basis of these facts, both the manual and the enzymatic method are equally expensive. Both methods are of course more expensive than the SMA 12/60 method (about 4 times).
Summarizing, we feel that the enzymatic method is a very valuable method, which is very specific for creatinine, and virtually insensitive to the interfering factors we tested. In its present form, the method is not readily adaptable to fully automated systems, but no doubt automated versions will be developed.
